Department of Medical Pharmacology, Gazi University, Faculty of Medicine, Ankara, Turkey.
Department of Radiology, Dr. Sami Ulus Training and Research Hospital, Ankara, Turkey.
Br J Radiol. 2020 Nov 1;93(1115):20200596. doi: 10.1259/bjr.20200596. Epub 2020 Sep 9.
Considering the growing use of imaging modalities and contrast agents, radiologists are prone to encounter adverse drug reactions (ADR). In the current study, we mainly aim to evaluate the knowledge of radiologists regarding pharmacovigilance (PV). Also, we intend to gather information about their previous ADR experiences. Secondarily, we hope to increase the awareness about contrast-medium-related ADRs and attract attention to the importance of properly reporting these ADRs.
A survey was generated by using an online survey webpage, and the relevant link was e-mailed to radiologists and radiology residents. The survey begins with a short explanation about the study. The second section contains questions about PV knowledge level, and the final section aims to gather information about the experienced ADRs.
The survey was completed by 202 participants. 65.3% stated that they were aware of PV. 24.8% of the participants said that they know the national PV program. 97% told that they knew the term ADR. 66.3% of the participants encountered an ADR. 53.7% of them reported these ADRs. 70.8% of them reported these ADRs to a clinician.
Radiologists encounter ADRs almost as frequently as the other doctors. Their awareness about PV is similar with other healthcare professionals. They have fewer information about TUFAM and PvCPs. Radiologists generally prefer to communicate with a clinician about an ADR. Overall condition of radiologists about PV is quite similar with other healthcare professionals and education can improve it, as for the others.
Radiologists encounters ADRs almost as frequently as the other doctors. Overall condition of radiologists about PV is quite similar with other healthcare professionals and education can improve it, as for the others.
考虑到成像方式和造影剂的使用越来越多，放射科医生容易遇到药物不良反应（ADR）。在本研究中，我们主要旨在评估放射科医生对药物警戒（PV）的了解。此外，我们还希望收集他们以前遇到的 ADR 经验的信息。其次，我们希望提高对与造影剂相关的 ADR 的认识，并引起人们对正确报告这些 ADR 的重要性的关注。
使用在线调查网页生成调查，并将相关链接通过电子邮件发送给放射科医生和放射科住院医师。调查首先简要解释了研究的目的。第二节包含有关 PV 知识水平的问题，最后一节旨在收集有关经历过的 ADR 的信息。
共有 202 名参与者完成了调查。65.3%的人表示他们了解 PV。24.8%的参与者表示他们知道国家 PV 计划。97%的人知道 ADR 一词。66.3%的参与者遇到过 ADR。53.7%的人报告了这些 ADR。70.8%的人向临床医生报告了这些 ADR。
放射科医生遇到 ADR 的频率几乎与其他医生一样高。他们对 PV 的认识与其他医疗保健专业人员相似。他们对 TUFAM 和 PvCPs 的了解较少。放射科医生通常更愿意与临床医生就 ADR 进行沟通。总体而言，放射科医生对 PV 的了解与其他医疗保健专业人员非常相似，并且可以像其他专业人员一样通过教育来提高。
放射科医生遇到 ADR 的频率几乎与其他医生一样高。总体而言，放射科医生对 PV 的了解与其他医疗保健专业人员非常相似，并且可以像其他专业人员一样通过教育来提高。
